RKLB Stock Analysis: Rocket Lab USA | NASDAQ

Launch Vehicles, Spacecraft, Space Systems, Optical

Total Rating 28

Safety 88

Buy Signal -1.11

Aerospace & Defense
Industry Rotation: -9.7

Market Cap: 42.3B
Avg Turnover: 1.27B

Risk 3d forecast

Volatility97.8%

VaR 5^th Pctl16.1%

VaR vs Median-0.20%

Reward TTM

Sharpe Ratio0.67

Rel. Str. IBD18.4

Rel. Str. Peer Group30.4

Character TTM

Beta3.534

Beta Downside2.431

Hurst Exponent0.559

Drawdowns 3y

Max DD60.99%

CAGR/Max DD1.89

CAGR/Mean DD5.29

EPS (Earnings per Share)

Last SUE: 0.47
Qual. Beats: 0

Revenue

Rev. CAGR: 54.62%
Rev. Trend: 99.6%

Last SUE: 0.79
Qual. Beats: 0

Warnings

Strong Share Dilution

High Debt/EBITDA With Thin Interest Coverage

High Debt While Negative Cash Flow

Interest Coverage Ratio Critical

Below Avwap Earnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 5.7 years of data

Jan -3.0% 10

Feb -2.3% 10

Mar -10.6% 46

Apr +7.5% 13

May +21.6% 34

Jun +14.3% 13

Jul +14.2% 34

Aug +4.5% 0

Sep -12.8% 25

Oct +7.3% 43

Nov +7.0% 11

Dec +3.3% 10

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: RKLB Rocket Lab USA

Rocket Lab Corporation (NASDAQ: RKLB) is a U.S.-based space company headquartered in Long Beach, California, that operates through two segments: launch services and space systems. The company provides end-to-end space solutions including launch services, spacecraft design and manufacturing, optical systems, on-orbit management, and constellation management services, serving commercial, aerospace prime contractor, and government customers across the United States, Canada, Japan, and other international markets.

The company is notable for its vertically integrated business model, designing and manufacturing much of its own hardware in-house, including small and medium-class rockets. Its flagship operational vehicle is the Electron, an orbital small launch vehicle, while the Neutron launch vehicle is in development for larger constellation deployments, interplanetary missions, and potentially human spaceflight. This dual-segment approach pairs rocket manufacturing with a growing space systems business that supplies components, subsystems, and software to other space operators.

Rocket Lab was founded in 2006 and completed its IPO on the Nasdaq on August 24, 2021, the same year it changed its corporate name from Rocket Lab USA, Inc. to Rocket Lab Corporation. It is classified within the GICS Industrials sector, under Industrial Machinery & Supplies & Components, reflecting its combined profile as both an aerospace launch provider and a manufacturer of space-grade hardware.

Headlines to Watch Out For

Neutron rocket development progresses toward maiden flight
Space Systems revenue scales with government satellite component orders
Launch cadence and backlog drive launch services growth

Piotroski VR-10 (Strict) 1.0

Net Income: -165.5m TTM > 0 and > 6% of Revenue
FCF/TA: -0.10 > 0.02 and ΔFCF/TA 3.62 > 1.0
NWC/Revenue: 307.8% < 20% (prev 124.9%; Δ 183.0% < -1%)
CFO/TA -0.06 > 3% & CFO -249.7m > Net Income -165.5m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 5.48 > 1.5 & < 3
Outstanding Shares: last quarter (629.7m) vs 12m ago 22.25% < -2%
Gross Margin: 37.26% > 18% (prev 29.04%; Δ 8.22% > 0.5%)
Asset Turnover: 26.80% > 50% (prev 32.47%; Δ -5.67% > 0%)
Interest Coverage Ratio: -24.71 > 6 (EBIT TTM -184.4m / Interest Expense TTM 7.46m)

Altman Z'' 7.69

A: 0.57 (Total Current Assets 2.90b - Total Current Liabilities 528.2m) / Total Assets 4.19b
B: -0.26 (Retained Earnings -1.11b / Total Assets 4.19b)
C: -0.06 (EBIT TTM -184.4m / Avg Total Assets 2.87b)
D: 5.02 (Book Value of Equity 3.49b / Total Liabilities 695.2m)
Altman-Z'' = 7.69 = AAA

Beneish M -3.02

DSRI: 0.54 (Receivables 112.9m/136.2m, Revenue 769.1m/504.3m)
GMI: 0.78 (GM 29.04% / 37.26%)
AQI: 1.35 (AQ_t 0.18 / AQ_t-1 0.14)
SGI: 1.53 (Revenue 769.1m / 504.3m)
TATA: 0.02 (NI -165.5m - CFO -249.7m) / TA 4.19b)
Beneish M = -3.02 (Cap -4..+1) = AA

What is the price of RKLB shares?

As of September 02, 2026, the stock is trading at USD 62.54 with a total of 14,156,543 shares traded. Over the past week, the price has changed by -6.53%, over one month by -11.20%, over three months by -48.90% and over the past year by +26.83%.

Current recommended Stop Loss: 56.60 (which is 9.5% or 1.3 ATR below the current price).

Is RKLB a buy, sell or hold?

Rocket Lab USA has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy RKLB.

StrongBuy: 7
Buy: 3
Hold: 5
Sell: 0
StrongSell: 0

What are the forecasts/targets for the RKLB price?

Analysts Target Price	112.9	80.6%

Rocket Lab USA (RKLB) - Fundamental Data Overview as of 28 August 2026

Market Cap USD = 42.3b (42.3b USD * 1.0 USD.USD)
P/S = 55.0172
P/B = 12.2512
Revenue TTM = 769.1m USD
EBIT TTM = -184.4m USD
EBITDA TTM = -122.1m USD
Long Term Debt = 154.1m USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 254.2m USD (corrected: LT Debt 154.1m + ST Debt none) + Leases 100.1m
Net Debt = -2.05b USD (calculated: Debt 254.2m - CCE 2.30b)
Enterprise Value = 40.3b USD (42.3b + Debt 254.2m - CCE 2.30b)
Interest Coverage Ratio = -24.71 (Ebit TTM -184.4m / Interest Expense TTM 7.46m)
EV/FCF = -101.1x (Enterprise Value 40.3b / FCF TTM -398.4m)
FCF Yield = -0.99% (FCF TTM -398.4m / Enterprise Value 40.3b)
FCF Margin = -51.79% (FCF TTM -398.4m / Revenue TTM 769.1m)
Net Margin = -21.51% (Net Income TTM -165.5m / Revenue TTM 769.1m)
Gross Margin = 37.26% ((Revenue TTM 769.1m - Cost of Revenue TTM 482.5m) / Revenue TTM)
Gross Margin QoQ = 36.13% (prev 38.18%)
Tobins Q-Ratio = 9.62 (Enterprise Value 40.3b / Total Assets 4.19b)
Interest Expense / Debt = 2.94% (Interest Expense 7.46m / Debt 254.2m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -145.7m (EBIT -184.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.48 (Total Current Assets 2.90b / Total Current Liabilities 528.2m)
Debt / Equity = 0.07 (Debt 254.2m / totalStockholderEquity, last quarter 3.49b)
Debt / EBITDA = 16.77 (negative EBITDA) (Net Debt -2.05b / EBITDA -122.1m)
Debt / FCF = 5.14 (negative FCF - burning cash) (Net Debt -2.05b / FCF TTM -398.4m)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.76% (Net Income -165.5m / Total Assets 4.19b)
RoE = -7.56% (Net Income TTM -165.5m / Total Stockholder Equity 2.19b)
RoCE = -7.87% (EBIT -184.4m / Capital Employed (Equity 2.19b + L.T.Debt 154.1m))
RoIC = -4.02% (negative operating profit) (NOPAT -145.7m / Invested Capital 3.62b)
WACC = 18.31% (E(42.3b)/V(42.6b) * Re(18.41%) + D(254.2m)/V(42.6b) * Rd(2.94%) * (1-Tc(0.21)))
Discount Rate = 18.41% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.13 | Cagr: 11.79%
[DCF] Fair Price = unknown (Cash Flow -398.4m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.47 | # QB: 0
Revenue Correlation: 99.58 | Revenue CAGR: 54.62% | SUE: 0.79 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.07 | Chg30d=-18.40% | Revisions=+17% | Analysts=5
EPS current Year (2026-12-31): EPS=-0.27 | Chg30d=-9.25% | Revisions=+17% | GrowthEPS=+27.5% | GrowthRev=+58.4%
EPS next Year (2027-12-31): EPS=-0.07 | Chg30d=N/A | Revisions=+17% | GrowthEPS=+72.5% | GrowthRev=+42.3%
[Analyst] Revisions Ratio: +25% (up=6, down=3)